Tags

Type your tag names separated by a space and hit enter

A comparative study of ultrasonication, Fenton's oxidation and ferro-sonication treatment for degradation of carbamazepine from wastewater and toxicity test by Yeast Estrogen Screen (YES) assay.
Sci Total Environ. 2013 Mar 01; 447:280-5.ST

Abstract

A comparative study of ultrasonication (US), Fenton's oxidation (FO) and ferro-sonication (FS) (combination of ultrasonication and Fenton's oxidation) advanced oxidation processes (AOPs) for degradation of carbamazepine (CBZ) from wastewater (WW) is reported for the first time. CBZ is a worldwide used antiepileptic drug, found as a persistent emerging contaminant in many wastewater treatment plants (WWTPs) effluents and other aquatic environments. The oxidation treatments of WW caused an effective removal of the drug. Among the various US, FO and FS pre-treatments carried out, higher soluble chemical oxygen demand (SCOD) and soluble organic carbon (SOC) increment (63 to 86% and 21 to 34%, respectively) was observed during FO pre-treatment process, resulting in higher removal of CBZ (84 to 100%) from WW. Furthermore, analysis of by-products formed during US, FO and FS pre-treatment in WW was carried out by using laser diode thermal desorption-atmospheric pressure chemical ionization (LDTD-APCI) coupled to tandem mass spectrometry (MS/MS). LDTD-APCI-MS/MS analysis indicated formation of two by-products, such as epoxycarbamazepine and hydroxycarbamazepine due to the reaction of hydroxyl radicals (OH) with CBZ during the three types of pre-treatment processes. In addition, the estrogenic activity of US, FO and FS pre-treated sample with CBZ and its by-products was carried out by Yeast Estrogen Screen (YES) assay method. Based upon the YES test results, none of the pre-treated samples showed estrogenic activity.

Authors+Show Affiliations

INRS-ETE, Université du Québec, 490, Rue de la Couronne, Québec, Canada G1K 9A9.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23410855

Citation

Mohapatra, D P., et al. "A Comparative Study of Ultrasonication, Fenton's Oxidation and Ferro-sonication Treatment for Degradation of Carbamazepine From Wastewater and Toxicity Test By Yeast Estrogen Screen (YES) Assay." The Science of the Total Environment, vol. 447, 2013, pp. 280-5.
Mohapatra DP, Brar SK, Tyagi RD, et al. A comparative study of ultrasonication, Fenton's oxidation and ferro-sonication treatment for degradation of carbamazepine from wastewater and toxicity test by Yeast Estrogen Screen (YES) assay. Sci Total Environ. 2013;447:280-5.
Mohapatra, D. P., Brar, S. K., Tyagi, R. D., Picard, P., & Surampalli, R. Y. (2013). A comparative study of ultrasonication, Fenton's oxidation and ferro-sonication treatment for degradation of carbamazepine from wastewater and toxicity test by Yeast Estrogen Screen (YES) assay. The Science of the Total Environment, 447, 280-5. https://doi.org/10.1016/j.scitotenv.2012.12.072
Mohapatra DP, et al. A Comparative Study of Ultrasonication, Fenton's Oxidation and Ferro-sonication Treatment for Degradation of Carbamazepine From Wastewater and Toxicity Test By Yeast Estrogen Screen (YES) Assay. Sci Total Environ. 2013 Mar 1;447:280-5. PubMed PMID: 23410855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A comparative study of ultrasonication, Fenton's oxidation and ferro-sonication treatment for degradation of carbamazepine from wastewater and toxicity test by Yeast Estrogen Screen (YES) assay. AU - Mohapatra,D P, AU - Brar,S K, AU - Tyagi,R D, AU - Picard,P, AU - Surampalli,R Y, Y1 - 2013/02/11/ PY - 2012/11/01/received PY - 2012/12/20/revised PY - 2012/12/21/accepted PY - 2013/2/16/entrez PY - 2013/2/16/pubmed PY - 2013/9/26/medline SP - 280 EP - 5 JF - The Science of the total environment JO - Sci. Total Environ. VL - 447 N2 - A comparative study of ultrasonication (US), Fenton's oxidation (FO) and ferro-sonication (FS) (combination of ultrasonication and Fenton's oxidation) advanced oxidation processes (AOPs) for degradation of carbamazepine (CBZ) from wastewater (WW) is reported for the first time. CBZ is a worldwide used antiepileptic drug, found as a persistent emerging contaminant in many wastewater treatment plants (WWTPs) effluents and other aquatic environments. The oxidation treatments of WW caused an effective removal of the drug. Among the various US, FO and FS pre-treatments carried out, higher soluble chemical oxygen demand (SCOD) and soluble organic carbon (SOC) increment (63 to 86% and 21 to 34%, respectively) was observed during FO pre-treatment process, resulting in higher removal of CBZ (84 to 100%) from WW. Furthermore, analysis of by-products formed during US, FO and FS pre-treatment in WW was carried out by using laser diode thermal desorption-atmospheric pressure chemical ionization (LDTD-APCI) coupled to tandem mass spectrometry (MS/MS). LDTD-APCI-MS/MS analysis indicated formation of two by-products, such as epoxycarbamazepine and hydroxycarbamazepine due to the reaction of hydroxyl radicals (OH) with CBZ during the three types of pre-treatment processes. In addition, the estrogenic activity of US, FO and FS pre-treated sample with CBZ and its by-products was carried out by Yeast Estrogen Screen (YES) assay method. Based upon the YES test results, none of the pre-treated samples showed estrogenic activity. SN - 1879-1026 UR - https://www.unboundmedicine.com/medline/citation/23410855/A_comparative_study_of_ultrasonication_Fenton's_oxidation_and_ferro_sonication_treatment_for_degradation_of_carbamazepine_from_wastewater_and_toxicity_test_by_Yeast_Estrogen_Screen__YES__assay_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0048-9697(12)01629-4 DB - PRIME DP - Unbound Medicine ER -